Sanofi (SNYNF) Consolidated Net Income (2009 - 2026)

Sanofi (SNYNF) has 18 years of Consolidated Net Income data on file, last reported at $30.4 million in Q1 2026.

• Quarterly Consolidated Net Income fell 83.37% year-over-year to $30.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 billion (up 3539.21% YoY) and the FY2025 annual result came in at $3.3 billion, up 4791.73% from the prior year.
• Consolidated Net Income grew to $30.4 million in Q1 2026 per SNYNF's latest filing, from -$3.3 billion in the prior quarter.
• The five-year high for Consolidated Net Income was $20.0 billion in Q4 2022, with the low at -$3.3 billion in Q4 2025.
• Average Consolidated Net Income over 5 years is $6.3 billion, with a median of $3.1 billion recorded in 2025.
• The widest YoY moves for Consolidated Net Income: up 7513.84% in 2025, down 1655.15% in 2025.
• Sanofi's Consolidated Net Income stood at $20.0 billion in 2022, then slumped by 102.36% to -$472.3 million in 2023, then soared by 59.73% to -$190.2 million in 2024, then sank by 1655.15% to -$3.3 billion in 2025, then jumped by 100.91% to $30.4 million in 2026.
• Business Quant data shows SNYNF's Consolidated Net Income at $30.4 million in Q1 2026, -$3.3 billion in Q4 2025, and $3.3 billion in Q3 2025.